Dibucaine hydrochloride

SKU: orb1710714

Description

Dibucaine hydrochloride (Cinchocaine HCl) is a long-acting amide-type local anesthetic primarily employed for surface anesthesia. It is utilized in research for studying nerve conduction blockade in both in vitro electrophysiology experiments and in vivo animal models of local anesthesia.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 61-12-1
• MW: 379.92
• Purity: 99.77%
• Formula: C₂₀H₃₀ClN₃O₂
• SMILES: Cl.CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
• Target: Sodium Channel,AChR
• Solubility: Ethanol:71 mg/mL (186.88 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.26 mM);DMSO:60 mg/mL (157.93 mM);H2O:70 mg/mL (184.25 mM)

Bioactivity

• In Vitro:
  Dibucaine (Cinchocaine) HCl is one of the most potent and toxic of the long-acting local anesthetics. Dibucaine (Cinchocaine) HCl blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions. This reversibly stabilizes the membrane and inhibits depolarization, resulting in the failure of a propagated action potential and subsequent conduction blockade.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Cinchocaine, Cinchocaine HCl, Cinchocaine Hydrochloride, Cinchocaine hydrochloride, Dibucaine, Dibucaine HCl, Dibucaine hydrochloride, Dibucaine Hydrochloride, AChR, BSA-gold, inhibit, Na channels, Na+ channels, Inhibitor, SChE, Sodium Channel, SodiumChannel

Compound Identifiers

PubChem CID

521951